January 13, 2026 05:13 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
10-minute delivery dead! Govt crackdown forces Blinkit, Swiggy and Zomato to backtrack after gig workers revolt | US tariff threats put India-Iran trade at risk – Chabahar Port becomes the high-stakes battleground! | Sensex slides 250 points as defence stocks bleed, Zomato parent Eternal soars | Markets rally big after US envoy calls India White House’s ‘most important ally’ | Kite diplomacy in Ahmedabad: Modi, German Chancellor share rare moment | ‘No ally more important than India’: US envoy sparks stock market rally | ED moves Supreme Court seeking CBI FIR against Mamata Banerjee over I-PAC raid chaos | Youngest ever! Owen Cooper wins Golden Globe as Adolescence dominates awards night | Timothée Chalamet beats DiCaprio, Clooney to win Golden Globe for Marty Supreme | Golden Globes 2026: DiCaprio’s film, Netflix series steal the show
Pfizer
Image: Wikimedia Commons

Pfizer launches pilot COVID-19 vaccine distribution preparedness program in 4 US states

| @indiablooms | Nov 17, 2020, at 10:14 pm

Moscow/Sputnik: US pharmaceutical company Pfizer announced in a press release on Tuesday it was launching a pilot program that aims to inform the delivery and distribution of its coronavirus vaccine in the US states of Rhode Island, Texas, New Mexico and Tennessee.

"To build on our coordination with the relevant U.S. agencies, Pfizer launched this pilot program to help better support the states’ planning, deployment, and administration of the COVID-19 vaccine candidate. Learnings from this program will be adapted for usage across other states to help them create effective immunization programs for this vaccine," the company said in a press release.

According to Pfizer, the four US states were selected due to their differences in overall size, diversity of populations, and immunization infrastructure, as well as the need to reach populations both in rural and urban areas.

In a disclaimer of future preferential benefits for these four states, the company has stressed that they "will not receive vaccine doses earlier than other states by virtue of this pilot, nor will they receive any differential consideration."

Pfizer developed the vaccine in collaboration with German biotechnology company BioNTech. As the unregistered vaccine is underway with phase 3 clinical trials, the creators have declared above 90-percent efficiency.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.